BlackRock Advisors’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$29.2M Buy
788,877
+275,969
+54% +$9.86M 0.03% 419
2016
Q3
$17.8M Sell
512,908
-3,005
-0.6% -$105K 0.02% 579
2016
Q2
$16.8M Sell
515,913
-15,363
-3% -$471K 0.02% 586
2016
Q1
$15.3M Sell
531,276
-2,186
-0.4% -$58.2K 0.02% 621
2015
Q4
$17.8M Buy
533,462
+321,059
+151% +$9.98M 0.02% 586
2015
Q3
$6.04M Buy
212,403
+181,888
+596% +$6.34M 0.01% 1021
2015
Q2
$1.24M Buy
30,515
+23,728
+350% +$1.07M ﹤0.01% 1528
2015
Q1
$334K Sell
6,787
-8,567
-56% -$397K ﹤0.01% 2373
2014
Q4
$698K Buy
+15,354
New +$603K ﹤0.01% 1737

Other funds holding AVNS

BlackRock Advisors's AVNS Position: Q4 2016 in Review

BlackRock Advisors increased its Avanos Medical (AVNS) stake by 54% in Q4 2016, buying an estimated $9.86M and bringing the position to 788,877 shares worth $29.2M. The position accounts for 0.03% of the portfolio, ranked #419.

BlackRock Advisors first reported a position in AVNS in Q4 2014 and has held it in 9 quarters since. 359 funds tracked by Wall St. Rank hold AVNS as of Q4 2016.

  • BlackRock Advisors held 788,877 shares of Avanos Medical worth $29.2M as of Q4 2016.
  • BlackRock Advisors bought 275,969 Avanos Medical shares in Q4 2016, an estimated $9.86M.
  • Avanos Medical made up 0.03% of BlackRock Advisors's portfolio in Q4 2016, its #419 holding.
  • BlackRock Advisors first reported a position in Avanos Medical in Q4 2014 and has held it in 9 quarters since.
  • 359 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.